Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era

被引：0
|
作者：
Sei Naito
Tomoyuki Kato
Kazuyuki Numakura
Shingo Hatakeyama
Tomoyuki Koguchi
Shuya Kandori
Yoshihide Kawasaki
Hisanobu Adachi
Renpei Kato
Shintaro Narita
Hayato Yamamoto
Soichiro Ogawa
Sadafumi Kawamura
Wataru Obara
Akihiro Ito
Hiroyuki Nishiyama
Yoshiyuki Kojima
Chikara Ohyama
Tomonori Habuchi
Norihiko Tsuchiya
机构：
[1] Yamagata University Faculty of Medicine,Department of Urology
[2] Akita University Graduate School of Medicine,Department of Urology
[3] Hirosaki University Graduate School of Medicine,Department of Urology
[4] Fukushima Medical University School of Medicine,Department of Urology
[5] University of Tsukuba Graduate School of Medicine,Department of Urology
[6] Tohoku University School of Medicine,Department of Urology
[7] Miyagi Cancer Center,Department of Urology
[8] Iwate Medical University School of Medicine,Department of Urology
来源：
International Journal of Clinical Oncology | 2021年 / 26卷
关键词：
Metastatic renal cell carcinoma; Overall survival; Prognosis; Prognostic model; Targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1947 / 1954
页数：7
相关论文
共 50 条
  • [41] CLINICAL IMPLICATION OF METASTASECTOMY IN METACHRONOUS METASTATIC RENAL CELL CARCINOMA IN THE ERA OF TARGETED THERAPY
    Kim, Jong Won
    Lee, Jongsoo
    Jeong, Jae Yong
    Kang, Sung Ku
    Han, Jang Hee
    Lee, Seung Hwan
    Ham, Won Sik
    Rha, Koon Ho
    Choi, Young Deuk
    Hong, Sung Joon
    Yoon, Young Eun
    Han, Woong Kyu
    JOURNAL OF UROLOGY, 2017, 197 (04): : E185 - E185
  • [42] Editorial Comment on: Prognosis of Japanese Metastatic Renal Cell Carcinoma Patients in the Cytokine Era: A Cooperative Group Report of 1463 Patients
    Ohlmann, Carsten-Henning
    EUROPEAN UROLOGY, 2010, 57 (02) : 325 - 326
  • [43] Management of metastatic renal cell carcinoma in the era of targeted therapies
    Webber, K.
    Cooper, A.
    Kleiven, H.
    Yip, D.
    Goldstein, D.
    INTERNAL MEDICINE JOURNAL, 2011, 41 (08) : 594 - 605
  • [44] ROLE OF MOLECULAR MARKERS IN NEPHRECTOMY SPECIMEN AS PROGNOSTICATORS FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA IN THE ERA OF TARGETED THERAPY
    You, Dalsan
    Cho, Yong Mee
    Lee, Jae-Lyun
    Song, Cheryn
    Hong, Jun Hyuk
    Kim, Choung-Soo
    Ahn, Hanjong
    JOURNAL OF UROLOGY, 2012, 187 (04): : E181 - E181
  • [45] Role of molecular markers in nephrectomy specimen as prognosticators for patients with metastatic renal cell carcinoma in the era of targeted therapy
    You, D.
    Cho, Y. M.
    Ahn, J. H.
    Lee, D. H.
    Lee, J. L.
    Hong, J. H.
    Kim, C. S.
    Ahn, H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E313 - E313
  • [46] Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era
    Marchioni, Michele
    Bandini, Marco
    Pompe, Raisa S.
    Tian, Zhe
    Martel, Tristan
    Kapoor, Anil
    Cindolo, Luca
    Berardinelli, Francesco
    Briganti, Alberto
    Shariat, Shahrokh F.
    Schips, Luigi
    Karakiewicz, Pierre I.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (12) : 2143 - 2149
  • [47] Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era
    Michele Marchioni
    Marco Bandini
    Raisa S. Pompe
    Zhe Tian
    Tristan Martel
    Anil Kapoor
    Luca Cindolo
    Francesco Berardinelli
    Alberto Briganti
    Shahrokh F. Shariat
    Luigi Schips
    Pierre I. Karakiewicz
    International Urology and Nephrology, 2017, 49 : 2143 - 2149
  • [48] The role of targeted therapy in metastatic renal cell carcinoma
    Unnithan, Jaya
    Rini, Brian I.
    THESCIENTIFICWORLDJOURNAL, 2007, 7 : 800 - 807
  • [49] An update on targeted therapy in metastatic renal cell carcinoma
    Lombardi, Giuseppe
    Zustovich, Fable
    Donach, Martin
    Dalla Palma, Maurizia
    Nicoletto, Ornella
    Pastorelli, Davide
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (03) : 240 - 246
  • [50] Outcome of metastatic renal cell carcinoma (mRCC) patients in the era of new targeted therapies
    Ruiz, A. L.
    Bolos, M. V.
    Viqueira, A.
    Esteban, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S654 - S654
12345